Target identification and mechanism of action in chemical biology and drug discovery

被引:2
|
作者
Schenone, Monica [1 ]
Dancik, Vlado [2 ]
Wagner, Bridget K. [2 ]
Clemons, Paul A. [2 ]
机构
[1] Broad Inst Harvard & MIT, Cambridge, MA USA
[2] Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
MAMMALIAN HISTONE DEACETYLASE; SMALL-MOLECULE PROBES; HIGH-THROUGHPUT; PROTEIN QUANTITATION; SELECTIVE ENRICHMENT; IN-VITRO; PROTEOMICS; EXPRESSION; GENETICS; PHARMACOLOGY;
D O I
10.1038/NCHEMBIO.1199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Target-identification and mechanism-of-action studies have important roles in small-molecule probe and drug discovery. Biological and technological advances have resulted in the increasing use of cell-based assays to discover new biologically active small molecules. Such studies allow small-molecule action to be tested in a more disease-relevant setting at the outset, but they require follow-up studies to determine the precise protein target or targets responsible for the observed phenotype. Target identification can be approached by direct biochemical methods, genetic interactions or computational inference. In many cases, however, combinations of approaches may be required to fully characterize on-target and off-target effects and to understand mechanisms of small-molecule action.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 50 条
  • [21] Drug discovery inspired by chemical biology
    Osada, Hiroyuki
    Imoto, Masaya
    CANCER SCIENCE, 2018, 109 : 149 - 149
  • [22] Mechanism-based target identification and drug discovery in cancer research
    Gibbs, JB
    SCIENCE, 2000, 287 (5460) : 1969 - 1973
  • [23] CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platform
    Kaya, Hikmet Emre
    Naidoo, Kevin J.
    BIOINFORMATICS, 2023, 39 (12)
  • [24] Chemogenomics in malaria: Using systems approaches in chemical biology and drug target discovery.
    Kuhen, Kelli
    Plouffe, David
    Henson, Kerstin
    Chen, Zhong
    Chatterjee, Amab
    Nagle, Advait
    Matzen, Jason
    Anderson, Paul
    Brinker, Achim
    Winzeler, Elizabeth
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2008, 38 : S96 - S96
  • [25] Chemical biology for target identification and validation
    Jones, Lyn H.
    Gray, Nathanael S.
    MEDCHEMCOMM, 2014, 5 (03) : 244 - 246
  • [26] Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery
    Blundell, TL
    Sibanda, BL
    Montalvao, RW
    Brewerton, S
    Chelliah, V
    Worth, CL
    Harmer, NJ
    Davies, O
    Burke, D
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1467) : 413 - 423
  • [27] Robust Target Identification for Drug Discovery
    Jacobsen, Elling W.
    Nordling, Torbjorn E. M.
    IFAC PAPERSONLINE, 2016, 49 (07): : 815 - 820
  • [28] Leveraging Chemotype-Specific Resistance for Drug Target Identification and Chemical Biology
    Kapoor, Tarun M.
    Miller, Rand M.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (12) : 1100 - 1109
  • [29] Cysteine-specific Chemical Proteomics: From Target Identification to Drug Discovery
    Hoch, Dominic G.
    Abegg, Daniel
    Wang, Chao
    Shuster, Anton
    Adibekian, Alexander
    CHIMIA, 2016, 70 (11) : 764 - 767
  • [30] Drug Discovery and Chemical Biology of Cancer Epigenetics
    Ribich, Scott
    Harvey, Darren
    Copeland, Robert A.
    CELL CHEMICAL BIOLOGY, 2017, 24 (09): : 1120 - 1147